Fresenius SE & Co KGaA (FRE) Given a €75.00 Price Target at Nord/LB

Nord/LB set a €75.00 ($87.21) price target on Fresenius SE & Co KGaA (FRA:FRE) in a report released on Thursday. The firm currently has a buy rating on the stock.

Several other equities analysts also recently issued reports on the stock. Morgan Stanley set a €77.00 ($89.53) price objective on shares of Fresenius SE & Co KGaA and gave the company a buy rating in a research note on Monday, September 3rd. Jefferies Financial Group set a €59.00 ($68.60) target price on shares of Fresenius SE & Co KGaA and gave the stock a neutral rating in a research note on Monday, October 1st. UBS Group set a €57.00 ($66.28) target price on shares of Fresenius SE & Co KGaA and gave the stock a sell rating in a research note on Monday, September 17th. Warburg Research set a €80.00 ($93.02) target price on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Friday, September 28th. Finally, Commerzbank set a €83.00 ($96.51) target price on shares of Fresenius SE & Co KGaA and gave the stock a buy rating in a research note on Tuesday, October 2nd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of €75.94 ($88.31).

FRA FRE traded down €1.60 ($1.86) during trading hours on Thursday, hitting €54.90 ($63.84). The company had a trading volume of 2,721,474 shares. Fresenius SE & Co KGaA has a 1-year low of €60.16 ($69.95) and a 1-year high of €80.00 ($93.02).

Fresenius SE & Co KGaA Company Profile

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Read More: Yield Curve

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply